News
- Author:
- Susan London
Publish date: December 26, 2019
Among patients given immune checkpoint inhibitors in the first-line setting, overall survival was more than twice as long for those with a good ver...
News
- Author:
- Susan London
Publish date: December 26, 2019
An update of the RTOG 0617 trial, now at a median follow-up of 5.1 years, finds that overall survival is better with standard-dose RT versus high-d...
News
- Author:
- Susan London
Publish date: December 16, 2019
Except among women with advanced serous tumors, surgery preserving the unaffected ovary and uterus was not associated with a significantly increase...
News
- Author:
- Susan London
Publish date: December 2, 2019
More than four in five patients were alive and free of disease progression a year after receiving chemoradiotherapy followed by ipilimumab, and thi...
News
- Author:
- Susan London
Publish date: November 19, 2019
At a median of 9 years of follow-up, progression-free survival was extended versus observation but there was no difference in overall survival.
News
- Author:
- Susan London
Publish date: November 14, 2019
A 17-gene expression signature may help predict which patients with IGHV-unmutated disease will benefit from frontline FCR chemoimmunotherapy or an...
News
- Author:
- Susan London
Publish date: November 11, 2019
On average, mean total costs of health care resources in the last month of life were 25% higher for SEER-Medicare patients compared with Ontario co...
News
- Author:
- Susan London
Publish date: November 7, 2019
A cohort study finds that patients treated with sunitinib as first-line therapy in routine clinical practice had poorer overall survival but also a...
News
- Author:
- Susan London
Publish date: November 5, 2019
A variety of physician and practice factors – some of them modifiable – increased the likelihood that oncologists discussed these often expensive a...
News
- Author:
- Susan London
Publish date: October 31, 2019
Lack of this cytoskeleton linker protein was associated with adverse prognostic factors and independently predicted poorer disease-specific surviva...
News
- Author:
- Susan London
Publish date: October 24, 2019
A stereotactic body radiation therapy regimen of 50 Gy given in five fractions had limited toxicity and yielded good survival in a cohort of patien...
News
- Author:
- Susan London
Publish date: October 23, 2019
Data for 127 patients treated at various doses showed that 54% had a response to the new third-generation EGFR TKI. Moreover, 44% of those with CNS...
News
- Author:
- Susan London
Publish date: October 21, 2019
Patients able to undergo nephrectomy after receiving immune checkpoint inhibitors had favorable surgical outcomes and pathologic responses in the p...
News
- Author:
- Susan London
Publish date: October 5, 2019
An update of CheckMate 067 finds that with combination nivolumab and ipilimumab therapy, 52% of patients were alive at 5 years, and the large major...
News
- Author:
- Susan London
Publish date: October 4, 2019
A cancer’s so-called epidemiologic signature – the composite pattern of incidence, mortality, and metastatic incidence – helps sort out the impacts...
